Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12308
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRobson, Neil Cen
dc.contributor.authorHidalgo, Lauraen
dc.contributor.authorMcAlpine, Tristanen
dc.contributor.authorWei, Hengen
dc.contributor.authorMartínez, Víctor Gen
dc.contributor.authorEntrena, Anaen
dc.contributor.authorMelen, Gustavo Jen
dc.contributor.authorMacDonald, Andrew Sen
dc.contributor.authorPhythian-Adams, Alexanderen
dc.contributor.authorSacedón, Rosaen
dc.contributor.authorMaraskovsky, Eugeneen
dc.contributor.authorCebon, Jonathan Sen
dc.contributor.authorRamírez, Manuelen
dc.contributor.authorVicente, Angelesen
dc.contributor.authorVaras, Albertoen
dc.date.accessioned2015-05-16T01:58:20Z
dc.date.available2015-05-16T01:58:20Z
dc.date.issued2014-07-18en
dc.identifier.citationCancer Research 2014; 74(18): 5019-31en
dc.identifier.govdoc25038228en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12308en
dc.description.abstractNatural killer (NK) cells are critical for innate tumor immunity due to their specialized ability to recognize and kill neoplastically transformed cells. However, NK cells require a specific set of cytokine-mediated signals to achieve optimal effector function. Th1-associated cytokines promote effector functions that are inhibited by the prototypic Th2 cytokine IL4 and the TGFβ superfamily members TGFβ1 and activin-A. Interestingly, the largest subgroup of the TGFβ superfamily are the bone morphogenetic proteins (BMP), but the effects of BMP signaling on NK cell effector functions have not been evaluated. Here, we demonstrate that blood-circulating NK cells express type I and II BMP receptors, BMP-2 and BMP-6 ligands, and phosphorylated isoforms of Smad-1/-5/-8, which mediate BMP family member signaling. In opposition to the inhibitory effects of TGFβ1 or activin-A, autocrine BMP signaling was supportive to NK cell function. Mechanistic investigations in cytokine and TLR-L-activated NK cells revealed that BMP signaling optimized IFNγ and global cytokine and chemokine production, phenotypic activation and proliferation, and autologous dendritic cell activation and target cytotoxicity. Collectively, our findings identify a novel auto-activatory pathway that is essential for optimal NK cell effector function, one that might be therapeutically manipulated to help eradicate tumors. Cancer Res; 74(18); 5019-31. ©2014 AACR.en
dc.language.isoenen
dc.subject.otherAutocrine Communicationen
dc.subject.otherBone Morphogenetic Protein Receptors.immunology.metabolismen
dc.subject.otherBone Morphogenetic Proteins.biosynthesis.genetics.immunology.metabolismen
dc.subject.otherCell Differentiation.immunologyen
dc.subject.otherHumansen
dc.subject.otherKiller Cells, Natural.immunology.metabolismen
dc.subject.otherRNA, Messenger.biosynthesis.geneticsen
dc.subject.otherSignal Transductionen
dc.titleOptimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling.en
dc.typeJournal Articleen
dc.identifier.journaltitleCancer researchen
dc.identifier.affiliationCSL Limited, Parkville, Melbourne, Victoria, Australiaen
dc.identifier.affiliationLudwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationInstitute of Infection, Immunity and Inflammation, The University of Glasgow, Glasgow, United Kingdom. neil.robson@ed.ac.uk avaras@bio.ucm.es.en
dc.identifier.affiliationDepartment of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain.en
dc.identifier.affiliationDepartment of Oncohematology, Niño Jesús Hospital, Madrid, Spain.en
dc.identifier.affiliationMCCIR, Core Technology Facility, The University of Manchester, Manchester, United Kingdom.en
dc.identifier.affiliationDepartment of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain. neil.robson@ed.ac.uk avaras@bio.ucm.es.en
dc.identifier.doi10.1158/0008-5472.CAN-13-2845en
dc.description.pages5019-31en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25038228en
dc.type.austinJournal Articleen
local.name.researcherCebon, Jonathan S
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Oct 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.